1. Home
  2. MRVI vs AMRC Comparison

MRVI vs AMRC Comparison

Compare MRVI & AMRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

N/A

Current Price

$7.29

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Ameresco Inc.

AMRC

Ameresco Inc.

N/A

Current Price

$24.07

Market Cap

1.2B

ML Signal

N/A

Company Overview

Basic Information
Metric
MRVI
AMRC
Founded
2014
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Engineering & Construction
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2020
2010

Fundamental Metrics

Financial Performance
Metric
MRVI
AMRC
Price
$7.29
$24.07
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$4.13
$37.88
AVG Volume (30 Days)
4.6M
678.5K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
14.29
N/A
EPS
N/A
N/A
Revenue
$185,743,000.00
$1,769,928,000.00
Revenue This Year
$12.54
$10.71
Revenue Next Year
$7.87
$9.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.55
$18.38
52 Week High
$9.42
$44.93

Technical Indicators

Market Signals
Indicator
MRVI
AMRC
Relative Strength Index (RSI) 47.43 45.59
Support Level $5.54 $21.63
Resistance Level $7.44 $23.99
Average True Range (ATR) 0.33 1.05
MACD -0.14 0.04
Stochastic Oscillator 17.23 26.90

Price Performance

Historical Comparison
MRVI
AMRC

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.

About AMRC Ameresco Inc.

Ameresco Inc is an energy infrastructure solutions provider dedicated to helping customers reduce costs, enhance resilience, and decarbonize to net zero in the energy transition. Its comprehensive portfolio includes implementing smart energy efficiency solutions, upgrading aging infrastructure, and developing, constructing, and operating distributed energy resources. Its solutions range from upgrades to facility's energy infrastructure to the development, construction and operation of renewable energy plants combined with tailored financial solutions. Its segments include North America Regions, U.S. Federal, Renewable Fuels, Europe, and Others. The majority of the revenue is derived from North America Regions segment.

Share on Social Networks: